Technical Analysis for GRCL - Gracell Biotechnologies Inc.

Grade Last Price % Change Price Change
F 11.555 0.65% 0.08
GRCL closed up 3.42 percent on Wednesday, July 28, 2021, on 20 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Flat
Historical GRCL trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.65%
Bollinger Band Squeeze Range Contraction 0.65%
BB Squeeze + Lower Band Touch Range Contraction 0.65%
BB Squeeze Started Range Contraction 0.65%
Outside Day Range Expansion 0.65%
Lower Bollinger Band Touch Weakness 0.65%
20 DMA Resistance Bearish 4.10%
Pocket Pivot Bullish Swing Setup 4.10%
Outside Day Range Expansion 4.10%
Fell Below 20 DMA Bearish -3.06%
Older End-of-Day Signals for GRCL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 3 hours ago
Gap Up Partially Closed about 6 hours ago
10 DMA Resistance about 6 hours ago
10 DMA Support about 6 hours ago
Gapped Up (Full) about 6 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Solid Tumors Immune System Health Sciences Cancer Immunotherapy Lymphoma Gene Therapy Chimeric Antigen Receptor T Cell

Is GRCL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.6999
52 Week Low 9.75
Average Volume 162,415
200-Day Moving Average 0.00
50-Day Moving Average 13.30
20-Day Moving Average 11.66
10-Day Moving Average 11.50
Average True Range 0.98
ADX 18.81
+DI 17.09
-DI 21.02
Chandelier Exit (Long, 3 ATRs) 10.50
Chandelier Exit (Short, 3 ATRs) 13.46
Upper Bollinger Bands 12.70
Lower Bollinger Band 10.62
Percent B (%b) 0.41
BandWidth 17.90
MACD Line -0.47
MACD Signal Line -0.52
MACD Histogram 0.0547
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.91
Resistance 3 (R3) 13.85 12.99 13.50
Resistance 2 (R2) 12.99 12.37 13.02 13.37
Resistance 1 (R1) 12.24 11.99 12.61 12.29 13.23
Pivot Point 11.37 11.37 11.56 11.40 11.37
Support 1 (S1) 10.62 10.76 11.00 10.67 9.73
Support 2 (S2) 9.76 10.37 9.78 9.59
Support 3 (S3) 9.00 9.76 9.46
Support 4 (S4) 9.05